MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 27 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $256,000 | +116.9% | 100,347 | +71.1% | 0.00% | – |
| Q1 2020 | $118,000 | +6.3% | 58,648 | +14.0% | 0.00% | – |
| Q4 2019 | $111,000 | +22.0% | 51,447 | -13.4% | 0.00% | – |
| Q3 2019 | $91,000 | -58.3% | 59,422 | +12.9% | 0.00% | – |
| Q2 2019 | $218,000 | +198.6% | 52,642 | +199.6% | 0.00% | – |
| Q1 2019 | $73,000 | +43.1% | 17,570 | -0.3% | 0.00% | – |
| Q4 2018 | $51,000 | -71.3% | 17,622 | -0.7% | 0.00% | – |
| Q3 2018 | $178,000 | +456.2% | 17,755 | +298.3% | 0.00% | – |
| Q2 2018 | $32,000 | -70.4% | 4,458 | -84.3% | 0.00% | – |
| Q1 2018 | $108,000 | -52.0% | 28,396 | +3.2% | 0.00% | – |
| Q4 2017 | $225,000 | +22400.0% | 27,523 | +5404.6% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 500 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | +200.0% | 500 | +400.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -88.9% | 100 | -87.5% | 0.00% | – |
| Q2 2015 | $9,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |